Collateral sensitivity to cisplatin in KB-8-5-11 drug-resistant cancer cells

Ben Doherty, Denise Lawlor, Jean-Pierre Gillet, Michael Gottesman, John J O'Leary, Britta Stordal

Résultats de recherche: Contribution à un journal/une revueArticleRevue par des pairs


BACKGROUND: KB-8-5-11 cells are a drug-resistant cervical cell model that overexpresses ABCB1 (P-glycoprotein). KB-8-5-11 has become sensitive to non-ABCB1 substrate cisplatin. Understanding the mechanism of collateral sensitivity to cisplatin may lead to biomarker discovery for platinum sensitivity in patients with cancer.

MATERIALS AND METHODS: A Taqman low-density array was used to characterize the expression of 380 genes previously associated with chemoresistance. Identified pathways were further analyzed using cytotoxicity assays, metabolomics and western blots.

RESULTS: KB-8-5-11 cells were sensitive to CuSO4 and the glutathione inhibitor buthionine sulphoximine. Expression of ATPase, Cu(2+) transporting alpha (ATP7A) and ATP7B were decreased at the protein and gene levels respectively in KB-8-5-11. KB-8-5-11 had decreased gene expression of glutathione S-transferase pi 1 (GSTP1), GSTA4 and GSTK1. Cisplatin treatment significantly lowered total cellular glutathione in parental KB-3-1 cells. Glutathione also tended to be lower in KB-8-5-11 cells compared to KB-3-1 cells.

CONCLUSION: KB-8-5-11 cells have alterations in their copper transporters and glutathione metabolism, contributing to their cisplatin-sensitive phenotype.

langue originaleAnglais
Pages (de - à)503-7
Nombre de pages5
journalAnticancer Research
Numéro de publication1
Etat de la publicationPublié - 2014

Empreinte digitale Examiner les sujets de recherche de « Collateral sensitivity to cisplatin in KB-8-5-11 drug-resistant cancer cells ». Ensemble, ils forment une empreinte digitale unique.

Contient cette citation